EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

CT‐derived simulations to predict outcomes in patients undergoing transcatheter aortic valve implantation with an ACURATE Neo2 valve the PRECISE‐TAVI cohort B trial

Thijmen W Hokken iD, Philippe Nuyens iD, Claudio Ruffo, Rutger-Jan Nuis, Joost Daemen iD, Isabella Kardys, Ricardo Budde, Nicola Buzzatti iD, Ole de Backer iD, Nicolas M Van Mieghem iD

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31194 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Thijmen W Hokken und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Aortic Valve, Heart Valve Prosthesis, Predictive Value of Tests, Prosthesis Design. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PRECISE-TAVI cohort B is part of a project that has received funding from the European Union's Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Paravalvular leakage (PVL) and conduction disorders that require permanent pacemaker implantation (PPI) remain clinically relevant challenges after transcatheter aortic valve implantation (TAVI). Computed tomography‐based simulations may predict the risk of significant PVL and PPI.

Aims

To evaluate the feasibility and accuracy of preprocedural computer simulation with FEops HEARTguide™ to predict >trace PVL and PPI after TAVI with the self‐expanding supra‐annular ACURATE Neo2 transcatheter heart valve.

Methods

Prospective multicenter observational study that included consecutive patients undergoing TAVI with an ACURATE Neo2 valve. Computer simulations were performed before the TAVI procedure as part of the preprocedural planning. Follow‐up period for PPI and PVL was 30 days.

Results

Sixty‐five patients were included (median age 81 years (25th−75th percentile 77–84.5)). New left bundle branch block occurred in five patients (7.7%) and PPI in two patients (3%). Contact pressure index (CPI) was similar for patients with vs without new conduction disorders. Patients with PPI had numerically higher CPI than those without PPI (median CPI 20.0% (25th−75th percentile 15.0–25.0) vs. 13.0% (25th−75th percentile 5.5–18), p = 0.27). More than trace PVL occurred in 30%. Median PVL was significantly lower in patients with none‐trace PVL (3.2 mL/s [25th−75th percentile 2.2–5.0]), compared to mild PVL (5.2 mL/s [25th−75th percentile 3.2–10.3]) and moderate PVL (12.6 mL/s [25th−75th percentile 3.9–21.3])( p = 0.036). A simulated PVL‐cutoff of 9.65 mL/s identified patients with >trace PVL (AUC 0.70 (95% CI 0.55–0.85), sensitivity 42%, specificity 95%).

Conclusion

In our study FEops HEARTguide™ simulations identified patients at risk for >trace PVL with ACURATE Neo2 TAVI but not for PPI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveHeart Valve ProsthesisPredictive Value of TestsProsthesis DesignTranscatheter Aortic Valve ReplacementTomography, X-Ray ComputedComputer SimulationAgedAged, 80 and overFemaleHumansMaleAortic Valve StenosisArrhythmias, CardiacCardiac Pacing, ArtificialFeasibility StudiesHemodynamicsModels, CardiovascularPatient-Specific ModelingProspective StudiesRadiographic Image Interpretation, Computer-AssistedRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeCohort Studies

Stichwörter der Autor:innen

computer simulationsconduction abnormalitiesparavalvular leakagetranscatheter aortic valve implantation

Autor:innen und Institutionen

  • Department of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Cardiac Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Thijmen W Hokken, Philippe Nuyens, Joost Daemen, Nicola Buzzatti, Ole de Backer, Nicolas M Van Mieghem

Förderung

  • PRECISE-TAVI cohort B is part of a project that has received funding from the European Union's Horizon 2020 research and innovation program

Zitieren

APA

Hokken, T. W., Nuyens, P., Ruffo, C., Nuis, R. J., Daemen, J., Kardys, I., Budde, R., Buzzatti, N., de Backer, O., & Van Mieghem, N. M. (2024). CT‐derived simulations to predict outcomes in patients undergoing transcatheter aortic valve implantation with an ACURATE Neo2 valve the PRECISE‐TAVI cohort B trial. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31194

Vancouver

Hokken TW, Nuyens P, Ruffo C, Nuis RJ, Daemen J, Kardys I, et al. CT‐derived simulations to predict outcomes in patients undergoing transcatheter aortic valve implantation with an ACURATE Neo2 valve the PRECISE‐TAVI cohort B trial. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31194

BibTeX
@article{Hokken2024,
  author = {Hokken, Thijmen W and Nuyens, Philippe and Ruffo, Claudio and Nuis, Rutger-Jan and Daemen, Joost and Kardys, Isabella and Budde, Ricardo and Buzzatti, Nicola and de Backer, Ole and Van Mieghem, Nicolas M},
  title = {CT‐derived simulations to predict outcomes in patients undergoing transcatheter aortic valve implantation with an ACURATE Neo2 valve the PRECISE‐TAVI cohort B trial},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31194}
}
Kostenlos starten →